2.Functional genomics studies of Salvia miltiorrhiza II--gene expression profiling of different stage of hairy root.
Guang-hong CUI ; Lu-qi HUANG ; De-you QIU ; Yuan YUAN ; Gui-fang FU
China Journal of Chinese Materia Medica 2007;32(13):1267-1272
OBJECTIVEStudying the gene expression profiling of different stage hairy root of Salvia miltiorrhiza, in order to find functional genes.
METHODThe contents of second metabolites were determined by HPLC and gene expression profiling was detected by cDNA microarray. cDNA labeled with a fluorescent dye (Cy5 and Cy3-dCTP) was produced by Eberwine's linear RNA amplification method and subsequent enzymatic reaction. The microarrays were scanned with a ScanArray Express scanner using ScanArray 2.0 software and quantified by signal intensities of individual spots from the 16-bit TIFF images using GenePix Pro 4.0. The linear normalization method was used for data analyze. Northern blot was used to test the gene expression results obtained by microarray. Different expressed genes were sequenced and analyzed by gap4 software, and then they were analyzed with BLASTX, BLASTN, GO and KEGG.
RESULTGrowth rate and second metabolites analysis indicated that the stage from 30 d to 45 d was the growth stage, while the stage from 45 d to 60 d was the second metabolites accumulation stage. Accordingly 30 d hairy root was chosen as a reference, which was hybridized with 45 d and 60 d hairy root separately. Total 203 different expressed genes were obtained. Northern blot showed that the result was identical with the microarray result. After sequenced, there were 172 genes clustered into 114 clusters (Unigenes). Among them, 62 unigenes had known functions, 34 unigenes were hypothetical protein, 9 unigenes were homologues with no similarity and 9 unigenes were unidentified protein with low similarity. Total 67 genes were classified into cellular component ontology, molecular function ontology and biological process ontology based on GO analysis. Total 26 genes, which represented 29 metabolic-related enzymes, were located in metabolic maps based on KEGG pathway classification.
CONCLUSIONSeveral important functional genes related to second metabolite synthesis were cloned such as P450 and copalyl diphosphate synthase genes. cDNA microarray was a useful tool for functional genomics of traditional Chinese medicine.
Alkyl and Aryl Transferases ; genetics ; metabolism ; Cytochrome P-450 Enzyme System ; genetics ; metabolism ; Gene Expression Profiling ; Gene Expression Regulation, Developmental ; Gene Expression Regulation, Plant ; Genomics ; methods ; Oligonucleotide Array Sequence Analysis ; Plant Proteins ; genetics ; metabolism ; Plant Roots ; genetics ; growth & development ; metabolism ; Plants, Medicinal ; genetics ; growth & development ; metabolism ; Salvia miltiorrhiza ; genetics ; growth & development ; metabolism
3.Chemical stability of Salvia miltirrhiza hairy root.
Dong-Mei LV ; Yuan YUAN ; Dong ZHANG ; Lu-Qi HUANG ; Ri-Xin LIANG ; De-You QIU
China Journal of Chinese Materia Medica 2008;33(6):653-656
OBJECTIVETo study on the chemical stability of Salvia miltirrhiza hairy root.
METHODThe rolA gene was detected by PCR in DNA and the chemical contituent variances were detected by HPLC.
RESULTThe rolA gene was found in all the 10 batches of the culfured hairy root. The similarities of the chromatographic fingerprints of the 10 batches are higher than 0. 95.
CONCLUSIONThere are no significant differences of the chemical constituents in 10 hairy root samples.
Chromatography, High Pressure Liquid ; DNA, Plant ; genetics ; Drugs, Chinese Herbal ; chemistry ; Genes, Plant ; Plant Roots ; chemistry ; genetics ; Polymerase Chain Reaction ; Reproducibility of Results ; Salvia miltiorrhiza ; chemistry ; genetics ; Sensitivity and Specificity
4.Effects of berberine on cyclin DI and CDK4 expressions in cells after focal cerebral ischemia reperfusion in rats
Zhe-Bin YOU ; Jie ZHANG ; De-Xiau ZHANG ; Zuo-Hui YUAN ; Fu-Qiang XU ; Yong-Zhe CHE
Chinese Journal of Neuromedicine 2008;7(8):788-792
Objective To explore the regulation of berberine on the expressions of CDK4 and cyclin D1 in the neurons after the focal cerebral ischemia/reperfusion and the potential protective mechanism of berberine to neurons. Methods Fifty male Wistar rats were randomly divided into berberine-treated group (n=15), normal control group (n=5), sham-operated group (n=15) and vehicle-treated group (n=15). The model of focal cerebral ischemia was constructed using middle cerebral artery occlusion (MCAO) method. At 1, 3, 5 d after 1 hour ofischemia, the expressions and distributions of Bcl-2, cyclin D1 and CDK4 in each group were detected by immunohistochemistry, and morphological changes of brain were observed by HE staining. Results HE staining showed that in the berberine-treated group, the number of neurons was decreased less than that in vehicle-treated group at reperfusion 3 and 5 d. For the result of immunohistochemistry for Bcl-2 positive neurons, there was no obvious difference between berberine-treated group and vehicle-treated group at reperfusion 1 d (P>0.05),however, the number of the Bcl-2 positive cells in berberine-treated group at reperfusion 3 and 5 was significantly increased (P<0.01), and the numbers of cyclin D 1 and CDK4 positive cells were decreased as compared with those in the vehicle-treated group. Conclusions In the rat focal ischemia model,berberine can inhibit the neural expressions of cyclin D1 and CDK4 in the penumbra, that indicates berberine may have the potential of neural protection. The possible mechanism is that berberine can decrease the neural expression ofcyclin D1 and prevent it from entering the nucleus, thereby blocking the cascade reaction and suppressing the apoptosis mediated by cyclin D1.
5.The relationship between the quality of liver biopsy tissue and the pathological diagnosis.
Yu-ping DING ; Kun DING ; Cai-chang ZHANG ; Zhi-qiang ZOU ; Bo LONG ; Zhen-wei LANG ; You-de LIU ; Qian LÜ ; Chun-qian QIANG ; Yuan-yuan LI
Chinese Journal of Hepatology 2010;18(11):867-868
Biopsy
;
methods
;
standards
;
Chronic Disease
;
Humans
;
Liver
;
pathology
;
Liver Diseases
;
diagnosis
;
pathology
;
Quality Control
6.A study on viral gastroenteritis attributed to noroviruses in hospitals.
Mei-fang CHEN ; Yan GAO ; Li-ping JIA ; You ZHANG ; Yuan QIAN ; Ying-hong WU ; Zheng ZHANG ; Ji-yan XIE ; Yi-de MIAO ; Lai WEI
Chinese Journal of Epidemiology 2007;28(2):141-143
OBJECTIVETo better understand the clinical feature of viral gastroenteritis attributed to noroviruses and to summarize the experience on an outbreak of acute gastroenteritis through rapidly colleting and confirmation of related information regarding to noroviruses in hospitals.
METHODSInformation on an outbreaks involving 18 patients with acute gastroenteritis in one hospital regarding its epidemiological and clinical features and to perform bacteria culture for stool specimens on every patient. On 7 patients, rotavirus antigen were RNA tested together with norovirus nucleic acid were examined by ELISA and PAGE and RT-PCR.
RESULTS(1) Most of the patients were elderly with several chronic diseases. (2) Watery diarrhea (12/18, 66.67%) and few with mucous (3/18, 16.67%) were seen. Most stool examination was normal (10/18, 55.56%) but few stool specimen could be found with some leucocytes (3/18, 16.67%) and little occult blood (4/18, 22.22%). (3) All bacteria culture in stools showed negative. There was no rotavirus RNA identified but 3 specimen showed norovirus nucleic acid positive as 42.86% (3/7).
CONCLUSIONNorovirus was one of the important pathogens causing acute gastroenteritis outbreaks in hospitals attacking elderly with several chronic diseases in particular. Surveillance program targeting elderly inpatient with diarrhea should be enhanced, especially in autumn and winter.
Acute Disease ; Aged ; Caliciviridae Infections ; epidemiology ; China ; epidemiology ; Disease Outbreaks ; Enzyme-Linked Immunosorbent Assay ; Feces ; virology ; Gastroenteritis ; epidemiology ; virology ; Hospitals ; statistics & numerical data ; Humans ; Norovirus ; isolation & purification ; Reverse Transcriptase Polymerase Chain Reaction
7.Cell-wall-deficient bacteria: a major etiological factor for psoriasis?
Guo-Li WANG ; Xiu-Yun LI ; Ming-Yi WANG ; De-Gui XIAO ; Yong-Yu ZHANG ; Xiao-Yan YUAN ; Qi-You WANG ; Jian-Jing SONG
Chinese Medical Journal 2009;122(24):3011-3016
BACKGROUNDPsoriasis is a common inflammatory skin disease, yet knowledge of the factors that may induce, trigger, or exacerbate psoriasis is not fully delineated. Recent advances have improved our understanding of the link between psoriasis and cell-wall-deficient bacteria (CWDB) infections. In the present study we assessed the prevalence of CWDB infection in patients with psoriasis.
METHODSThe carriage rate of CWDB in the tonsil or pharynx of psoriasis patients, chronic tonsillitis patients and controls were investigated using hypertonic medium. Psoriasis patients with CWDB were randomly assigned to two groups and respectively treated with antibiotics or systemic therapy without antibiotic. Human peripheral blood mononuclear cells (PBMC) from psoriasis patients, chronic tonsillitis patients and control subjects were stimulated with bacteria antigens and extra-cellular levels of interferon-gamma (IFN-gamma) and interleukin (IL)-10 were measured in the supernatants using the ELISA technique, in vitro. Meanwhile, the proliferation ability of PBMC to respond to bacteria antigens was detected by MTT assay.
RESULTSCWDB were isolated from 74.2% of psoriasis patients, 23.5% of chronic tonsillitis patients and only 6.3% of controls. Antibiotic therapy was appropriate for approximately 80% of psoriasis patients with CWDB infection, and in only 8.9% psoriasis patients CWDB infection was detected after antibiotic therapy. Meanwhile, our study showed that CWDB and wide-type bacteria did remarkably enhance the production of IFN-gamma, in vitro, and PBMC proliferation.
CONCLUSIONCWDB infection may be a virtual triggering factor in psoriasis by regulating T-cell activation.
Adult ; Anti-Bacterial Agents ; therapeutic use ; Bacteria ; cytology ; drug effects ; isolation & purification ; Cell Wall ; metabolism ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Interferon-gamma ; metabolism ; Interleukin-10 ; metabolism ; Male ; Middle Aged ; Psoriasis ; drug therapy ; etiology ; metabolism ; microbiology ; Young Adult
8.Capsule metadoxine in the treatment of alcoholic liver disease: a randomized, double-blind, placebo-controlled, multicenter study.
Yi-Min MAO ; Min-de ZENG ; You-Ming LI ; Bing-Yuan WANG ; Jia SHANG ; Rui-Hua SHI ; Ji-Yong LIU ; Lun-Gen LU ; Ai-Ping CAO
Chinese Journal of Hepatology 2009;17(3):213-216
OBJECTIVETo evaluate the efficacy and safety of Capsule metadoxine in the treatment of alcoholic liver disease.
METHODSA randomized double blind multicenter placebo-controlled clinical study was performed to evaluate the therapeutic effectiveness and safety of capsule metadoxine. Patients in metadoxine group received capsule metadoxine 500mg tid po. Patients in placebo group received placebo 2 pillows tid po. The treatment duration was 6 weeks. Patients were followed up 2 weeks after the treatment. Patients were visited once every 3 weeks during the treatment period. Clinical symptoms and liver function were evaluated in all the patients before treatment, at week 3, week 6 and 2 weeks after therapy. CT scan was done in some patients before treatment and at the end point of therapy.
RESULTS254 patients were recruited in the study, 126 in metadoxine group and 128 in placebo group. Median ALT, AST, GGT level in metadoxine group were decreased from 80.0 U/L, 59.2 U/L, 123.0 U/L (before treatment) to 41.1 U/L, 36.0 U/L, 57.0 U/L (after 6 weeks therapy). The improvement in liver function was more significant in metadoxine group than in placebo group (P less than 0.05). For the patients who stopped drinking during the study, the total effective rate of improvement in liver function was 82.8% in metadoxine group, much higher than that in placebo group (55.7% , P=0.0000). For the patients who did not stop drinking during the study, the total effective rate of improvement in liver function was 65.4% in metadoxine group, which is not significantly higher than that in placebo group (44.8%, P=0.1767). The CT value ratio of liver to spleen was significantly improved in metadoxine group (P=0.0023), and there was no significant difference between the two groups (P=0.6293). The rate of adverse was 1.6% in both of groups.
CONCLUSIONCapsule metadoxine is an effective and safe treatment for alcoholic liver disease.
Administration, Oral ; Adult ; Aged ; Alanine Transaminase ; blood ; Alcohol Deterrents ; administration & dosage ; therapeutic use ; Analysis of Variance ; Aspartate Aminotransferases ; blood ; Capsules ; Double-Blind Method ; Drug Combinations ; Fatty Liver, Alcoholic ; blood ; drug therapy ; pathology ; Female ; Follow-Up Studies ; Humans ; Liver ; diagnostic imaging ; pathology ; Liver Diseases, Alcoholic ; blood ; drug therapy ; pathology ; Liver Function Tests ; Male ; Middle Aged ; Pyridoxine ; administration & dosage ; therapeutic use ; Pyrrolidonecarboxylic Acid ; administration & dosage ; therapeutic use ; Treatment Outcome ; Ultrasonography ; Young Adult ; gamma-Glutamyltransferase ; blood
9.Antitumor activity of the recombinant rClone30-CD/5-FC system.
Zheng LU ; Tian-Yuan ZHANG ; Miao-Miao HAN ; Fu-Liang BAI ; Wei WU ; Gui-You TIAN ; Gui-Ping REN ; De-Shan LI
Acta Pharmaceutica Sinica 2013;48(2):261-268
5-Flucytosine (5-FC) could be changed to 5-fluorouracil (5-FU) by cytosine deaminase (CD), the latter is able to kill cancer cells. However, there is no efficient method to deliver the CD gene into the tumor cells, which hampers the application of the suicide gene system. In this experiment, for the first time, the NDV has been utilized as a vector to deliver the CD gene into the cancer cells, the virus can infect the cancer cells specifically, replicate and assemble, while the cytosine deaminase is expressed. Then the CD converts the prodrug 5-FC into 5-FU to achieve the purpose of inhibiting tumor. Firstly, the whole genome of E. coli JM109 was extracted, and the CD gene was obtained by cloning method. Then the CD and IRES-EGFP were ligated into the pEE12.4 expression vector to become a recombinant pEE12.4IE-CD eukaryotic expression plasmid. The human liver cancer cells were transfected with the plasmid. The cells were treated with different concentrations of 5-FC, MTT method was used to determine the killing effect of CD/5-FC system on the human liver cancer cells. The cell deaths were 18.07%, 42.98% and 62.20% respectively when the concentrations of prodrug were at 10, 20 and 30 mmol x L(-1). In 5-FC acute toxicity experiment, Kunming mice were injected with different concentrations of 5-FC at intervals of 1:0.5. The LD50 of 5-FC through iv injection was determined by improved Karber's method, the LD50 was 507 mg x kg(-1) and the 95% confidence limit was 374-695 mg x kg(-1). According to the maximum LD0 dose of the LD50, the maximum safe dose was 200 mg x kg(-1). Body weight and clinic symptoms of the experimental animals were observed. These results laid the foundation to verify the antitumor effect and safety of CD/5-FC system in animal models. The CD gene was ligated into the NDV (rClone30) carrier, then the tumor-bearing animal was established to perform the tumor inhibiting experiment. The result showed that the recombinant rClone30-CD/5-FC system has a high antitumor activity in vivo. To summarize, CD gene has been cloned and its bioactivity has been confirmed in the mammalian cells. It is the first time in this study to utilize the recombinant NDV to deliver the CD gene into the tumor cells; our result proves the rClone30-CD/5-FC system is a potential method for cancer therapy.
Animals
;
Antimetabolites, Antineoplastic
;
metabolism
;
pharmacology
;
Cell Death
;
drug effects
;
Chick Embryo
;
Cytosine Deaminase
;
genetics
;
metabolism
;
Escherichia coli
;
genetics
;
metabolism
;
Flucytosine
;
metabolism
;
pharmacology
;
Fluorouracil
;
metabolism
;
pharmacology
;
Genetic Vectors
;
Hep G2 Cells
;
Humans
;
Lethal Dose 50
;
Liver Neoplasms, Experimental
;
pathology
;
Mice
;
Newcastle disease virus
;
genetics
;
Plasmids
;
Recombinant Proteins
;
genetics
;
metabolism
;
Transfection
;
Tumor Burden
;
drug effects
10.Combination of AD5-10 and epirubicin in treating rheumatoid arthritis.
Jian-suo ZHOU ; Juan SHI ; Jie-qing ZHU ; Hai-qin YUAN ; Yan-xin LIU ; Xin YOU ; De-xian ZHENG
Acta Academiae Medicinae Sinicae 2011;33(4):367-370
OBJECTIVETo investigate the mechanism of anti-death receptor 5-10 (AD5-10) combined with epirubicin in treating rheumatoid arthritis (RA).
METHODSWe detected the cell viability of the fibroblast-like synoviocytes (FLS) from RA patients with MTT. The expression level of apoptosis signaling pathways protein, p53, and p21 were evaluated with Western blot.
RESULTSWe found that epirubicin, at different doses, could enhance the effect of AD5-10 on FLS, promoting the apoptosis of FLS. The expression levels of caspase-3, -8, -9, c-FLIP, Bcl-2, p53, and p21 in the FLS changed after epirubicin treatment.
CONCLUSIONEpirubicin may coordinate with AD5-10 in inducing FLS apoptosis through affecting the levels of p53, p21, c-FLIP, and Bcl-2.
Antibodies, Monoclonal ; pharmacology ; Apoptosis ; drug effects ; Apoptosis Regulatory Proteins ; metabolism ; Arthritis, Rheumatoid ; drug therapy ; metabolism ; pathology ; Cells, Cultured ; Epirubicin ; pharmacology ; Humans ; Receptors, TNF-Related Apoptosis-Inducing Ligand ; immunology ; Synovial Membrane ; cytology ; drug effects ; metabolism